Primary CNS lymphoma (PCNSL) is a rare and aggressive brain tumour that is uniformly fatal. The rarity of the disease and the poor response to treatment makes it difficult to reach a consensus with regards to treatment options. In this review, the authors have discussed different treatment modalities used in the management of PCNSL including chemotherapy, surgery and radiation, as well as the results of recent clinical trials on treatment options for PCNSL.
|Number of pages||2|
|Journal||JPMA. The Journal of the Pakistan Medical Association|
|Publication status||Published - Mar 2018|
- Cerebral malignancy
- Primary CNS Lymphoma